Table 3 CE US LI-RADS classification in cases with diagnosis of ultrasomics and pathology
| Â | Pathology | Ultrasomics | LR-4 | LR-5 | LR-M | LR-TIV | |
|---|---|---|---|---|---|---|---|
With LR-5 | With LR-M | ||||||
Entire cohort (159) | HCC | HCC | 2 | 64 | 28 | 5 | 4 |
Non-HCC | 0 | 2 | 1 | 0 | 0 | ||
CHC | HCC | 0 | 0 | 3 | 0 | 0 | |
Non-HCC | 0 | 14 | 36 | 0 | 0 | ||
Validation cohort (48) | HCC | HCC | 0 | 23 | 4 | 1 | 1 |
Non-HCC | 0 | 2 | 1 | 0 | 0 | ||
CHC | HCC | 0 | 0 | 2 | 0 | 0 | |
Non-HCC | 0 | 2 | 12 | 0 | 0 | ||